Table of Contents Table of Contents
Previous Page  21 / 398 Next Page
Information
Show Menu
Previous Page 21 / 398 Next Page
Page Background

16

Abstracts

material has been used in cleft lip and palate patients requiring

bone grafting of the alveolar cleft defect

. 1–5 It

s use has been often

combined with autogenous bone, requiring a second surgical site

to harvest the bone. This is a review of the outcomes of 98 patients

that have received only Infuse

®

rhBMP-2 plus allograft (Puros

®

)

between 2008 and 2015.

Methods:

Patient charts from 2008 to 2016 were reviewed. The

patients were all grafted with a small rhBMP-2 kit (4.2 mg) plus

1 g of Puros for the unilateral case and a medium rhBMP-2 kit

(8.4 mg split evenly between sites) plus 2 g of Puros (split evenly

between sites) for the bilateral cleft patients. ICAT scans were

used preoperatively, 1 week postoperatively and from 3 months to

99 months of follow-up changes were used to evaluate the erup-

tion of the canine in the cleft site, the need for exposure of the

canine, the density change (in Hounsfield units) of the graft and

the percentage of graft retained in the site. The height, width, and

depth of the grafted bone were also measured and the change over

time recorded. 15 cases were chosen randomly to assess the ICAT

cone-beam scans changes in volume and density, height, width

and depth of the grafts. Two were bilateral and 13 were unilateral.

The engineers at 3D systems used software to overlay the scans

and assess then record these changes.

Results:

Of the 98 patients, 61 were males and 37 females. Age

of the patients ranged from 4 to 48 years. There we 63 unilateral

and 35 bilateral cases. For the purpose of this evaluation the right

side was used in the bilateral cases to evaluate ICAT measure-

ments for the volume studies. The canines were still developing

in 48 patients, the canines erupted in 46 patients and the canines

needed exposure in 4 patients. The ICAT scans of the 15 patients

showed the following changes and overall 5.76% increase in over-

all volume. A 6.89% increase in average height, a 17.19%decrease

in average width, and a 7.39% decrease in average depth. The

Density change was an 82.23% increase.

Conclusion:

The use of rhBMP-2 demonstrated predictable

results for maintaining enough volume and density to allow for

development and eruption of the permanent canine in 46 out of

98 patients thus far. The remaining 48 patients will be followed

and recorded. Only 4 patients have required exposure. The volume

changes of the graft show an increase over time of 5.76 percent

along with an 82.23% increase in density. The bone achieved has

thus far provided stability of the dentoalveolar unit as well as

adequate bone volume to support the dentition.

Reference

1 Dickinson, B. P., Ashley, R. K., Wasson, K. L., O’Hara, C., Gabbay, J.,

Heller, J. B., et al. (2008). Reduced morbidity and improved healing with

bone morphogenic protein-2 in older patients with alveolar cleft defects.

Plast Reconstr Surg

,

121

, 209–217.

2 Alonso, N., Tanikawa, D. Y., Freitas Rda, S., Canan, L., Jr., Ozawa, T. O.,

& Rocha, D. L. (2010). Evaluation of maxillary alveolar reconstruction

using a resorbable collagen sponge with recombinant human bone mor-

phogenetic protein-2 in cleft lip and palate patients.

Tissue Eng Part C

Methods

,

16

, 1183–1189.

3 van Hout, W. M., Mink van der Molen, A. B., Breugem, C. C.,

Koole, R., & Van Cann, E. M. (2011). Reconstruction of the alveo-

lar cleft: can growth factor-aided tissue engineering replace autologous

bone grafting? A literature review and systematic review of results

obtained with bone morphogenetic protein-2.

Clin Oral Investig

,

15

,

297–303.

4 Canan, L. W., Jr., da Silva Freitas, R., Alonso, N., Tanikawa, D. Y., Rocha,

D. L., & Coelho, J. C. (2012). Human bone morphogenetic protein-2 use

for maxillary reconstruction in cleft lip and palate patients.

J Craniofac

Surg

,

23

, 1627–1633.

5 Ayoub, A., Roshan, C. P., Gillgrass, T., Naudi, K., & Ray, A. (2016). The

clinical application of rhBMP-7 for the reconstruction of alveolar cleft.

J

Plast Reconstr Aesthet Surg

,

69

, 101–107.

http://dx.doi.org/10.1016/j.ijom.2017.02.056

Craniofacial fibrous dysplasia: current treatment options

L. Dubois

∗

, R. Schreurs, P. Saeed, A.G. Becking

Academic Medical Center Amsterdam, The Netherlands

Fibrous dysplasia is a rare, benign, slowly growing fibro-osseous

disease, resulting in bone deformities, fractures and neurologic

compression. Epidemiology, clinical signs and symptoms and

radiologic findings in a cohort of 35 patients with periorbital cra-

niofacial fibrous dysplasia will be discussed with emphasis on

occurrence and treatment of optical nerve compression.

Computer-assisted planning and surgery shows very promising

results in simultaneous static and dynamic guidance in correcting

craniofacial fibrous dysplasia. With virtual planning it is possi-

ble to transfer the preoperative planning to surgery with the use of

helpful guides in order to exactly achieve the planned result. Static

guidance is delivered with the use of additive manufactured tem-

plates, which are inserted during surgery and define the planned

position and orientation. In dynamic guidance image-guided nav-

igation is used. Templates will be rigidly positioned with use of

navigation and they will deliver control at local level, as in acting

as a sawing or drilling mall. Navigation can subsequently be used

to assess the overall result in surgery.

The combination of these two modalities is rather new and

delivers extraordinary benefits for surgical outcomes.

http://dx.doi.org/10.1016/j.ijom.2017.02.057

Management of ameloblastomas: maxillary, mandibular, and

malignant types

D. Dyalram

University of Maryland Medical Center, Baltimore, MD, United

States

To this day, controversy exists in the management of ameloblas-

toma. The University of Maryland Oral Maxillofacial Surgery

department, Oncology Service, has had the opportunity to treat a

large number of these benign aggressive tumours. We would like

to share our observations and lessons learned on the behaviour,

management and reconstruction of these three unique types of

ameloblastoma.

http://dx.doi.org/10.1016/j.ijom.2017.02.058

“Tips” to facilitate orthognathic surgery

E. Ellis III

University of Texas Health Science Center at San Antonio, TX,

United States

Orthognathic surgery can be facilitated and/or enhanced by vari-

ous techniques and procedures. This lecture will present several

diverse orthognathic surgery topics that can be useful when treat-

ing patients.

Creating maxillary primate spaces prior to surgery: A sim-

ple way to facilitate the best possible occlusion is to have the